Contra-indicated in patients with hypokalemia, hypomagnesemia, or long QT syndrome.
Antineoplastic / anticancer agent (see also Immune checkpoint inhibitor)
Vascular endothelial growth factor (VEGF) inhibitor / antagonist
Contra-indicated in patients with hypokalemia, hypomagnesemia, or long QT syndrome.
See full prescribing information for complete boxed warning.
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of nilotinib in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 06/26/2025